Haizheng [adamumumab injection] pricing announced!
-
Last Update: 2020-01-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On January 2, Shaanxi provincial centralized procurement network of pharmaceutical machinery released the announcement on direct network hanging of adamumumab injection In accordance with the relevant requirements of "about to do well" (Shaanxi medical insurance Fa [2019] No 29) issued by the provincial medical insurance bureau, the provincial human resources and social security department and the provincial health and Health Commission, the adamutumab injection (drug serial number: 1730989, specification: 0.8ml: 40mg, net price limit: 1150 yuan) produced by Haizheng biopharmaceutical Co., Ltd )And adamumumab injection (drug serial number: 1731067, specification: 0.8ml: 40mg) produced by bio Pharmaceutical Co., Ltd of baiaotai will be publicized on the Internet Publicity period: from January 2, 2020 to 17:00, January 3, 2020, during the publicity period, the company will accept the written application and complaint of the real name of the enterprise on site, and will not accept any more after the time limit Acceptance place of application and complaint: No.5 and No.6 window of acceptance hall on the first floor of Shaanxi public resources trading center (No.14, Chang'an North Road, Beilin District, Xi'an city) contact number: 029-88661243 029-88661244 Shaanxi public resources trading center January 2, 2020 The medical insurance payment standard of Semel is 1290 yuan / piece, and the price of Haizheng adamumumab injection (0.8ml: 40mg) is 1150 yuan / piece, 140 yuan lower than that of Semel No pricing has been announced Adorable adorable
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.